Προωθημένο
Advancing Cancer Immunotherapy with Anti-CCR8 Antibodies
Emergence and Importance of Anti-CCR8 Antibodies Anti-CCR8 antibodies have gained attention as a novel class of immunotherapies aimed at enhancing anti-tumor immunity by targeting regulatory T cells (Tregs) within the tumor microenvironment. These antibodies act on the CCR8 chemokine receptor, highly expressed on tumor-infiltrating Tregs that suppress immune responses and facilitate cancer...
0 Σχόλια 0 Μοιράστηκε 64 Views 0 Προεπισκόπηση
Προωθημένο
Προωθημένο
Προωθημένο